v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (27,488,000) $ (53,706,000)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 2,890,000 2,239,000
Issuance of common stock for reward 870,000
Stock based payments for professional services rendered 190,000
Stock based payments to employees and directors 13,000 19,000
(Loss) gain on equity method investment 16,000 (1,000)
Unrealized loss (gain) on investment in marketable securities 531,000 (224,000)
Amortization of operating lease ROU assets 640,000 745,000
Write off of inventory 419,000
Provision for inventory obsolescence (127,000)
Loss (gain) on sale of real estate assets 9,622,000 (14,000)
Impairment of fixed assets 264,000
Impairment of investments of investments at cost 782,000
Impairment of real estate 2,420,000 7,288,000
Impairment of intangibles 600,000
Provision for loan losses 20,000 4,398,000
Gain on extinguishment of debt (595,000)
Impairment of goodwill 25,093,000
Decrease (increase) in assets:    
Accounts receivable 558,000 1,142,000
Inventory 152,000 377,000
Prepaid expenses and other current assets 642,000 778,000
Investment in trading securities (316,000) (3,327,000)
Other assets 91,000 (65,000)
Increase (decrease) in liabilities:    
Accounts payable (196,000) (861,000)
Accrued expenses (926,000) 140,000
ROU liabilities (614,000) (686,000)
Accrued interest on notes payable 2,083,000 3,648,000
Other liabilities (624,000) 3,210,000
Net cash used by operating activities (9,129,000) (8,761,000)
Cash flows from investing activities:    
Purchase of property, plant and equipment (268,000) (133,000)
Purchase of real estate (38,000) (140,000)
Proceeds from sale of real estate 15,713,000
Proceeds from sale of equity investments 3,023,000
Proceeds from disposal of property, plant and equipment 5,609,000
Proceeds from sale of investment, related party 2,414,000
Issuance of new notes receivable, net origination fees (459,000)
Payments received on notes receivable 250,000 4,132,000
Payments received on notes receivable, related party 106,000
Net cash provided by investing activities 18,071,000 12,138,000
Cash flows from financing activities:    
Payments of long-term debt (17,809,000) (2,626,000)
Borrowings of long-term debt, net 3,250,000 876,000
Borrowings of convertible note payable - related party 500,000
Issuances of common stock, net of issuance costs 3,189,000
Net cash provided (used) by financing activities (14,059,000) 1,439,000
Net increase (decrease) in cash (5,117,000) 4,816,000
Cash and cash equivalents at beginning of year 11,431,000 6,615,000
Total cash and restricted cash 6,314,000 11,431,000
Cash and cash equivalents 6,214,000 11,431,000
Restricted cash $ 100,000